Spartalizumab
id:
spartalizumab-250-10180182
title:
Spartalizumab
text:
Spartalizumab is a monoclonal antibody and checkpoint inhibitor that is being investigated for melanoma. This drug is being developed by Novartis. As of 2018, spartalizumab is undergoing Phase III trials.
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Spartalizumab
date created:
date modified:
2023-05-30T01:28:46Z
main entity:
{"identifier":"Q60785560","url":"https://www.wikidata.org/entity/Q60785560"}
image:
fields total:
13
integrity:
14